Results 41 to 50 of about 3,176,059 (188)

Being ‘at-home’ on outpatient parenteral antimicrobial therapy (OPAT): a qualitative study of parents’ experiences of paediatric OPAT [PDF]

open access: yesArchives of Disease in Childhood, 2019
ObjectiveTo better understand the factors that facilitate and hinder a positive experience of paediatric outpatient parenteral antimicrobial therapy (OPAT).DesignQualitative study using semistructured interviews.SettingA dedicated paediatric consultant-led hospital-based, outreach OPAT service in England.ParticipantsParticipants were primarily parents ...
Bernie Carter   +7 more
openaire   +4 more sources

Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections

open access: yesFrontiers in Medicine, 2020
Since the 1970s, outpatient parenteral antimicrobial therapy (OPAT) has been a viable option for patients who require intravenous antibiotics when hospitalization is not warranted.
Tristan Ferry   +12 more
doaj   +1 more source

Effectiveness and safety of a disposable elastomeric continuous infusion pump for outpatient parenteral antimicrobial therapy (OPAT) in a UK setting

open access: yes, 2023
We evaluated the effectiveness and safety of continuous antimicrobial infusion using a disposable elastomeric device in an outpatient parenteral antimicrobial therapy (OPAT) setting.
Evangelos I. Kritsotakis (9584094)   +2 more
core   +1 more source

Comparing Self-Administered Outpatient Parenteral Antimicrobial Therapy (S-OPAT) with Alternative Delivery Models: Risk Factors for Treatment Failure and Complications in a UK Cohort

open access: yesPathogens
Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) is an increasingly recognised antimicrobial delivery model, yet comparative evidence on its safety and effectiveness remains limited.
Oyewole Christopher Durojaiye   +3 more
doaj   +1 more source

Real-world outpatient parenteral antimicrobial therapy before national reimbursement: a retrospective cohort study from a Taiwanese cancer hospital

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Before Taiwan’s national outpatient parenteral antimicrobial therapy (OPAT) reimbursement, we retrospectively evaluated 241 OPAT episodes among 173 patients at a cancer hospital.
Kai-Ming Chang   +7 more
doaj   +1 more source

Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience. [PDF]

open access: yesJAC Antimicrob Resist
Background: Outpatient parenteral antimicrobial therapy (OPAT) is safe, effective and increasingly available. While OPAT in Norwegian healthcare has been rare, a new continuous ambulatory delivery device (CADD) allowing multiple daily dosing treatments
Skogen V   +4 more
europepmc   +2 more sources

Delivery, setting and outcomes of paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): a scoping review [PDF]

open access: yesBMJ Open, 2018
Background There has been little detailed systematic consideration of the delivery, setting and outcomes of paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT), although individual studies report that it is a safe and effective treatment ...
Bernie Carter   +6 more
openaire   +3 more sources

Staff team perceptions of the Maltese outpatient parenteral antimicrobial therapy service. [PDF]

open access: yes, 2020
The Outpatient Parenteral Antimicrobial Therapy (OPAT) service was developed to cater for hospitalised patients receiving antimicrobial treatment and who are stable enough to be discharged to an outpatient or home setting.
Vosper, Helen   +2 more
core   +5 more sources

Outpatient parenteral antimicrobial therapy for orthopedic infections – a successful public healthcare experience in Brazil

open access: yesBrazilian Journal of Infectious Diseases, 2016
Treatment of orthopedic infections usually requires prolonged antimicrobial therapy, ranging from 14 days up to 6 months. Nowadays, rising levels of antimicrobial resistance demands parenteral therapy for many patients.
Priscila Rosalba Oliveira   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy